Insights into oral microbiome and colorectal cancer - on the way of searching new perspectives.

Anna Kudra, Damian Muszyński, Bartosz Kamil Sobocki, Alessandro Atzeni, Ludovico Carbone, Karolina Kaźmierczak-Siedlecka, Karol Połom, Leszek Kalinowski

Journal: Frontiers in cellular and infection microbiology 2023;13():1159822

PMID: 37124035

Abstract

Microbiome is a keystone polymicrobial community that coexist with human body in a beneficial relationship. These microorganisms enable the human body to maintain homeostasis and take part in mechanisms of defense against infection and in the absorption of nutrients. Even though microbiome is involved in physiologic processes that are beneficial to host health, it may also cause serious detrimental issues. Additionally, it has been proven that bacteria can migrate to other human body compartments and colonize them even although significant structural differences with the area of origin exist. Such migrations have been clearly observed when the causes of genesis and progression of colorectal cancer (CRC) have been investigated. It has been demonstrated that the oral microbiome is capable of penetrating into the large intestine and cause impairments leading to dysbiosis and stimulation of cancerogenic processes. The main actors of such events seem to be oral pathogenic bacteria belonging to the red and orange complex (regarding classification of bacteria in the context of periodontal diseases), such as and respectively, which are characterized by significant amount of cancerogenic virulence factors. Further examination of oral microbiome and its impact on CRC may be crucial on early detection of this disease and would allow its use as a precise non-invasive biomarker.

Copyright © 2023 Kudra, Muszyński, Sobocki, Atzeni, Carbone, Kaźmierczak-Siedlecka, Połom and Kalinowski.

Address: Scientific Circle of Studies Regarding Personalized Medicine Associated with Department of Medical Laboratory Diagnostics, Medical University of Gdansk, Gdansk, Poland.; Scientific Circle of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.; Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.; Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Unitat de Nutrició, Reus, Spain.; Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.; Department of Medicine Surgery and Neuroscience, University of Siena, Siena, Italy.; Department of Medical Laboratory Diagnostics - Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk, Gdansk, Poland.; Department of Surgical Oncology, Medical University of Gdansk, Gdansk, Poland.; Department of Medical Laboratory Diagnostics - Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk, Gdansk, Poland.; BioTechMed Centre, Department of Mechanics of Materials and Structures, University of Technology, Gdansk, Poland.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.